|
|
|
|
LEADER |
01241nom a2200337 u 4500 |
001 |
10069459 |
003 |
upatras |
005 |
20210117201542.0 |
008 |
090512s2007 eng |
020 |
|
|
|a 9783540495291
|
040 |
|
|
|a GR-PaULI
|c GR-PaULI
|
041 |
0 |
|
|a eng
|
100 |
1 |
|
|a Venitz, J.
|9 64215
|
245 |
1 |
0 |
|a Appropriate Dose Selection β How to Optimize Clinical Drug Development
|h [electronic resource]
|c edited by J. Venitz, W. Sittner
|
260 |
|
|
|a Berlin, Heidelberg
|b Springer-Verlag Berlin Heidelberg
|c 2007
|
300 |
|
|
|b v.: digital
|
490 |
0 |
|
|a Ernst Schering Research Foundation Workshop
|v 59
|x 0947-6075
|
650 |
|
4 |
|a Medicine
|9 11026
|
650 |
|
4 |
|a Toxicology
|9 13539
|
650 |
|
4 |
|a Biochemistry
|9 10061
|
650 |
|
4 |
|a Biomedicine
|9 64032
|
650 |
|
4 |
|a Pharmacology/Toxicology
|9 64073
|
650 |
|
4 |
|a Medicine/Public Health, general
|9 64075
|
650 |
|
4 |
|a Biochemistry, general
|9 64024
|
700 |
1 |
|
|a Sittner, W.
|9 64216
|
760 |
1 |
|
|a Ernst Schering Research Foundation Workshop
|g 59
|x 0947-6075
|
852 |
|
|
|a GR-PaULI
|b ΠΑΤΡΑ
|b ΒΚΠ
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-3-540-49529-1
|
942 |
|
|
|2 ddc
|
952 |
|
|
|0 0
|1 0
|4 0
|7 0
|9 70904
|a LISP
|b LISP
|d 2016-04-24
|l 0
|r 2016-04-24 00:00:00
|w 2016-04-24
|y ERS
|
999 |
|
|
|c 45705
|d 45705
|